Back to today’s briefing

Story perspectives

Revolutionary Breath Test for Pancreatic Cancer Trials Begin

10/29/2025

31 3

Summary

Story summary

A breath test for pancreatic cancer from Imperial College London could transform detection.
The test detects volatile organic compounds in breath and will trial 6,000 patients at 40 sites in England, Wales, Scotland.
Diana Jupp, CEO of Pancreatic Cancer UK, calls it a milestone.
Pancreatic cancer is often diagnosed late, with only 7% surviving five years.
If successful, it could be available in general practitioner (GP) surgeries within five years.

1 of 1

Story summary

A breath test for pancreatic cancer from Imperial College London could transform detection.
The test detects volatile organic compounds in breath and will trial 6,000 patients at 40 sites in England, Wales, Scotland.
Diana Jupp, CEO of Pancreatic Cancer UK, calls it a milestone.
Pancreatic cancer is often diagnosed late, with only 7% surviving five years.
If successful, it could be available in general practitioner (GP) surgeries within five years.